-+ 0.00%
-+ 0.00%
-+ 0.00%
Spago Nanomedical Shareholders Approve Delisting Application at Extraordinary Meeting
Share
Listen to the news
Spago Nanomedical Shareholders Approve Delisting Application at Extraordinary Meeting
  • Spago Nanomedical shareholders approved the board's delisting application resolution for Nasdaq First North Growth Market at the November 19, 2026, extraordinary meeting.
  • The preliminary timetable schedules the application for January 25, 2027, with a decision expected in January 2027.
  • Subject to approval, trading would end in February 2027, no earlier than two weeks following Nasdaq Stockholm's decision.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Spago Nanomedical AB published the original content used to generate this news brief on November 19, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending